{"transactions":[{"id":3465315,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-07-09T20:18:37.000Z","date":"2019-07-07","kind":"disposition_to_issuer","acquired":false,"shares":285473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The following restricted stock units were forfeited as a result of the Reporting Person's separation of service from the Issuer effective as of July 7, 2019: (a) 89,402 restricted stock units granted to the Reporting Person on May 25, 2017; (b) 47,222 restricted stock units granted to the Reporting Person on May 24, 2018; (c) 7,556 restricted stock units granted to the Reporting Person on May 24, 2018 that related to an award with a performance condition tied to relative total shareholder return; (d) 84,776 restricted stock units granted to the Reporting Person on March 7, 2019; and (e) restricted stock units, with a target amount of 56,517, granted to the Reporting Person on March 7, 2019 contingent upon achievement of a performance condition tied to relative total shareholder return."}],"balance_after":464528,"source":{"system":"sec-edgar","filing":"0001209191-19-041549","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919119041549/doc4.xml","form_type":"4"}},{"id":3474915,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-07-01T20:06:21.000Z","date":"2019-06-28","kind":"other","acquired":true,"shares":3334,"price":1.7,"value":5667.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired under the Issuer's Employee Stock Purchase Plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the purchase price for each share purchased under the Employee Stock Purchase Plan and equals 85% of the fair market value of common stock on June 28, 2019, being the exercise date under the plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (a) a deferred stock award of 56,517 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on March 7, 2020, 2021 and 2022, contingent upon achievement of a performance condition tied to relative total shareholder return; (b) a deferred stock award of 113,034 restricted stock units which shall vest in four equal installments on January 1, 2020, 2021, 2022 and 2023; (c) a deferred stock award of 70,833 restricted stock units which vest in equal installments on January 1, 2020, 2021 and 2022; (d) a deferred stock award of 178,804 restricted stock units which shall vest in equal installments on January 1, 2020 and 2021; (e) a deferred stock award of 72,916 restricted stock units which shall vest on January 1, 2020;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"continuation of footnote 3 above: (f) a deferred stock award of 7,556 restricted stock units, which vest in equal installments on May 24, 2020 and May 24, 2021; and (g) 250,341 shares of common stock held by the Reporting Person."}],"balance_after":750001,"source":{"system":"sec-edgar","filing":"0001209191-19-039695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919119039695/doc4.xml","form_type":"4"}},{"id":3509136,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-05-29T21:07:27.000Z","date":"2019-05-24","kind":"tax_withholding","acquired":false,"shares":1111,"price":2.31,"value":2566.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain restricted stock units previously granted to the Reporting Person on May 24, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 56,517 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on March 7, 2020, 2021 and 2022, contingent upon achievement of a performance condition tied to relative total shareholder return; (b) a deferred stock award of 113,034 restricted stock units which shall vest in four equal installments on January 1, 2020, 2021, 2022 and 2023; (c) a deferred stock award of 70,833 restricted stock units which vest in equal installments on January 1, 2020, 2021 and 2022; (d) a deferred stock award of 178,804 restricted stock units which shall vest in equal installments on January 1, 2020 and 2021; (e) a deferred stock award of 72,916 restricted stock units which shall vest on January 1, 2020;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"continuation of footnote 2 above: (f) a deferred stock award of 7,556 restricted stock units, which vest in equal installments on May 24, 2020 and May 24, 2021; and (g) 247,007 shares of common stock held by the Reporting Person.    With respect to the performance based deferred stock award received on May 24, 2018, the Reporting Person had previously included the target number of such award, being 94,444 shares, in his reported holdings, and on May 24, 2019, the actual earned award amount was determined to be 11,333.  As such, the 83,111 shares previously reported but not earned are no longer included in the securities beneficially owned."}],"balance_after":746667,"source":{"system":"sec-edgar","filing":"0001209191-19-033245","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919119033245/doc4.xml","form_type":"4"}},{"id":3556811,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-04-12T20:06:18.000Z","date":"2019-04-12","kind":"sale","acquired":false,"shares":400,"price":4.65,"value":1860.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes the awards referenced in clauses (a) through (f) of footnotes (3) and (4) above, plus 244,340 shares of common stock held by the Reporting Person."}],"balance_after":830888,"source":{"system":"sec-edgar","filing":"0001209191-19-024470","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919119024470/doc4.xml","form_type":"4"}},{"id":3556810,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-04-12T20:06:18.000Z","date":"2019-04-11","kind":"sale","acquired":false,"shares":12425,"price":4.51,"value":56036.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.50 to $4.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes the awards referenced in clauses (a) through (f) of footnotes (3) and (4) above, plus 244,740 shares of common stock held by the Reporting Person."}],"balance_after":831288,"source":{"system":"sec-edgar","filing":"0001209191-19-024470","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919119024470/doc4.xml","form_type":"4"}},{"id":3556809,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-04-12T20:06:18.000Z","date":"2019-04-10","kind":"sale","acquired":false,"shares":6332,"price":4.5,"value":28494.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.50 to $4.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (a) a deferred stock award of 56,517 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on March 7, 2020, 2021 and 2022, contingent upon achievement of a performance condition tied to relative total shareholder return; (b) a deferred stock award of 113,034 restricted stock units which shall vest in four equal installments on January 1, 2020, 2021, 2022 and 2023; (c) a deferred stock award of 70,833 restricted stock units which vest in equal installments on January 1, 2020, 2021 and 2022; (d) a deferred stock award of 178,804 restricted stock units which shall vest in equal installments on January 1, 2020 and 2021; (e) a deferred stock award of 72,916 restricted stock units which shall vest on January 1, 2020;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"continuation of footnote 3 above: (f) a deferred stock award of 94,444 restricted stock units with performance based vesting conditions, which if earned shall vest in equal installments on May 24, 2019, 2020 and 2021, and are contingent upon achievement of a performance condition tied to relative shareholder return; and (g) 257,165 shares of common stock held by the Reporting Person."}],"balance_after":843713,"source":{"system":"sec-edgar","filing":"0001209191-19-024470","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919119024470/doc4.xml","form_type":"4"}},{"id":3569356,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2019-04-02T20:56:06.000Z","date":"2019-03-07","kind":"grant","acquired":true,"shares":271139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options vest in four equal installments on January 1, 2020, 2021, 2022 and 2023."}],"balance_after":271139,"derivative":{"exercise_price":3.79,"expiration_date":"2029-03-07","underlying":"Common Stock, par value $0.01 per share","underlying_shares":271139},"source":{"system":"sec-edgar","filing":"0001209191-19-022619","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919119022619/doc4.xml","form_type":"4"}},{"id":3569355,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-04-02T20:56:06.000Z","date":"2019-03-07","kind":"grant","acquired":true,"shares":56517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a deferred stock award of 56,517 restricted stock units with performance based vesting conditions. These restricted stock units shall vest in equal installments on March 7, 2020, 2021 and 2022, and are linked to the achievement of a relative total shareholder return of the Issuer's common stock from March 7, 2019 to the earlier of (i) March 7, 2020 or (ii) upon a change of control (measured relative to the NASDAQ Biotechnology index and based on the 20-day trading average price before each such date). The target number of these restricted stock units that may be earned is reported above; the maximum amount is 150% of the number reported."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes (a) the shares and awards described in footnote (2) above, and (b) the award described in footnote (3) above."}],"balance_after":850045,"source":{"system":"sec-edgar","filing":"0001209191-19-022619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919119022619/doc4.xml","form_type":"4"}},{"id":3569354,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-04-02T20:56:06.000Z","date":"2019-03-07","kind":"grant","acquired":true,"shares":113034,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a deferred stock award of 113,034 restricted stock units which shall vest in four equal installments on January 1, 2020, 2021, 2022 and 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 113,034 restricted stock units which shall vest in four equal installments on January 1, 2020, 2021, 2022 and 2023; (b) a deferred stock award of 70,833 restricted stock units which vest in equal installments on January 1, 2020, 2021 and 2022; (c) a deferred stock award of 178,804 restricted stock units which shall vest in equal installments on January 1, 2020 and 2021; (d) a deferred stock award of 72,916 restricted stock units which shall vest on January 1, 2020; (e) a deferred stock award of 94,444 restricted stock units with performance based vesting conditions, which if earned shall vest in equal installments on May 24, 2019, 2020 and 2021, and are contingent upon achievement of a performance condition tied to relative total shareholder return; and (f) 263,497 shares of common stock held by the Reporting Person."}],"balance_after":793528,"source":{"system":"sec-edgar","filing":"0001209191-19-022619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919119022619/doc4.xml","form_type":"4"}},{"id":3709622,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-01-03T21:12:44.000Z","date":"2019-01-01","kind":"tax_withholding","acquired":false,"shares":61755,"price":3.18,"value":196380.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were disposed to satisfy the Reporting Person's tax withholding obligation in connection with deferred stock awards previously granted to the Reporting Person which vested in part on January 1, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 94,444 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on May 24, 2019, May 24, 2020 and May 24, 2021, contingent upon achievement of a performance condition tied to relative total shareholder return; (b) a deferred stock award of 70,833 restricted stock units which shall vest in three equal installments on January 1, 2020, 2021 and 2022; (c) a deferred stock award of 178,804 restricted stock units which shall vest in three equal installments on January 1, 2020 and 2021; (d) a deferred stock award of 72,916 restricted stock units which shall vest on January 1, 2020; and (e) 263,497 shares of common stock held by the Reporting Person."}],"balance_after":680494,"source":{"system":"sec-edgar","filing":"0001209191-19-000905","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919119000905/doc4.xml","form_type":"4"}},{"id":3846335,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-08-13T20:09:10.000Z","date":"2018-08-03","kind":"tax_withholding","acquired":false,"shares":12619,"price":5.7,"value":71928.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were disposed to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain restricted stock units previously granted to the Reporting Person on August 3, 2015."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 94,444 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on May 24, 2019, May 24, 2020 and May 24, 2021, contingent upon achievement of a performance condition tied to relative total shareholder return; (b) a deferred stock award of 94,444 restricted stock units which shall vest in four equal installments on January 1, 2019, 2020, 2021 and 2022; (c) a deferred stock award of 268,206 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (d) a deferred stock award of 145,833 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (e) a deferred stock award of 17,225 restricted stock units which shall vest in full on January 1, 2019; and (f) 122,097 shares of common stock held by the Reporting Person."}],"balance_after":742249,"source":{"system":"sec-edgar","filing":"0001209191-18-046402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118046402/doc4.xml","form_type":"4"}},{"id":3848754,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-08-09T21:00:52.000Z","date":"2018-08-09","kind":"exercise","acquired":false,"shares":44500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":350000,"derivative":{"exercise_price":4.31,"exercise_date":"2016-11-18","expiration_date":"2023-11-18","underlying":"Common Stock, par value $0.01 per share","underlying_shares":394500},"source":{"system":"sec-edgar","filing":"0001209191-18-046059","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118046059/doc4.xml","form_type":"4"}},{"id":3848753,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-08-09T21:00:52.000Z","date":"2018-08-08","kind":"exercise","acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":394500,"derivative":{"exercise_price":4.31,"exercise_date":"2016-11-18","expiration_date":"2013-11-18","underlying":"Common Stock, par value $0.01 per share","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001209191-18-046059","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118046059/doc4.xml","form_type":"4"}},{"id":3848752,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-08-09T21:00:52.000Z","date":"2018-08-07","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":400000,"derivative":{"exercise_price":4.31,"exercise_date":"2016-11-18","expiration_date":"2023-11-18","underlying":"Common Stock, par value $0.01 per share","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001209191-18-046059","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118046059/doc4.xml","form_type":"4"}},{"id":3848751,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-08-09T21:00:52.000Z","date":"2018-08-09","kind":"sale","acquired":false,"shares":44500,"price":6.41,"value":285245.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.35 to $6.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (9)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes the awards referenced in clauses (a) through (f) of footnotes (2) and (3) above plus 98,842 shares of common stock held by the Reporting Person."}],"balance_after":790742,"source":{"system":"sec-edgar","filing":"0001209191-18-046059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118046059/doc4.xml","form_type":"4"}},{"id":3848750,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-08-09T21:00:52.000Z","date":"2018-08-09","kind":"exercise","acquired":true,"shares":44500,"price":4.31,"value":191795.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Includes the awards referenced in clauses (a) through (f) of footnotes (2) and (3) above plus 143,342 shares of common stock held by the Reporting Person."}],"balance_after":835242,"source":{"system":"sec-edgar","filing":"0001209191-18-046059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118046059/doc4.xml","form_type":"4"}},{"id":3848749,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-08-09T21:00:52.000Z","date":"2018-08-08","kind":"sale","acquired":false,"shares":5500,"price":6.35,"value":34925.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.35 to $6.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (7)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes the awards referenced in clauses (a) through (f) of footnotes (2) and (3) above plus 98,842 shares of common stock held by the Reporting Person."}],"balance_after":790742,"source":{"system":"sec-edgar","filing":"0001209191-18-046059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118046059/doc4.xml","form_type":"4"}},{"id":3848748,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-08-09T21:00:52.000Z","date":"2018-08-08","kind":"exercise","acquired":true,"shares":5500,"price":4.31,"value":23705.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes the awards referenced in clauses (a) through (f) of footnotes (2) and (3) above plus 104,342 shares of common stock held by the Reporting Person."}],"balance_after":796242,"source":{"system":"sec-edgar","filing":"0001209191-18-046059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118046059/doc4.xml","form_type":"4"}},{"id":3848747,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-08-09T21:00:52.000Z","date":"2018-08-07","kind":"sale","acquired":false,"shares":100000,"price":6.07,"value":607000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.15 to $6.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes the awards referenced in clauses (a) through (f) of footnotes (2) and (3) above plus 98,842 shares of common stock held by the Reporting Person."}],"balance_after":790742,"source":{"system":"sec-edgar","filing":"0001209191-18-046059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118046059/doc4.xml","form_type":"4"}},{"id":3848746,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-08-09T21:00:52.000Z","date":"2018-08-07","kind":"exercise","acquired":true,"shares":100000,"price":4.31,"value":431000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 94,444 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on May 24, 2019, May 24, 2020 and May 24, 2021, contingent upon achievement of a performance condition tied to relative total shareholder return; (b) a deferred stock award of 94,444 restricted stock units which shall vest in four equal installments on January 1, 2019, 2020, 2021 and 2022; (c) a deferred stock award of 268,206 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (d) a deferred stock award of 145,833 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (e) a deferred stock award of 17,225 restricted stock units which shall vest in full on January 1, 2019; (continued in footnote 3 below)"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"(continuation of footnote 3 above) (f) a deferred stock award of 71,748 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (g) 198,842 shares of common stock held by the Reporting Person."}],"balance_after":890742,"source":{"system":"sec-edgar","filing":"0001209191-18-046059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118046059/doc4.xml","form_type":"4"}},{"id":3869521,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-07-12T00:12:46.000Z","date":"2018-07-11","kind":"sale","acquired":false,"shares":14205,"price":5.22,"value":74150.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.175 to $5.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (7)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Includes the awards referenced in clauses (a) through (f) of footnotes (3) and (4) above plus 98,842 shares of common stock held by the Reporting Person."}],"balance_after":790742,"source":{"system":"sec-edgar","filing":"0001209191-18-042406","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118042406/doc4.xml","form_type":"4"}},{"id":3869520,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-07-12T00:12:46.000Z","date":"2018-07-10","kind":"sale","acquired":false,"shares":11600,"price":5.38,"value":62408.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.28 to $5.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes the awards referenced in clauses (a) through (f) of footnotes (3) and (4) above plus 113,047 shares of common stock held by the Reporting Person."}],"balance_after":804947,"source":{"system":"sec-edgar","filing":"0001209191-18-042406","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118042406/doc4.xml","form_type":"4"}},{"id":3869519,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-07-12T00:12:46.000Z","date":"2018-07-09","kind":"sale","acquired":false,"shares":14195,"price":5.41,"value":76794.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.38 to $5.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (a) a deferred stock award of 94,444 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on May 24, 2019, May 24, 2020 and May 24, 2021, contingent upon achievement of a performance condition tied to relative total shareholder return; (b) a deferred stock award of 94,444 restricted stock units which shall vest in four equal installments on January 1, 2019, 2020, 2021 and 2022; (c) a deferred stock award of 268,206 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (d) a deferred stock award of 145,833 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (e) a deferred stock award of 17,225 restricted stock units which shall vest in full on January 1, 2019;"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"continuation of footnote 3 above) (f) a deferred stock award of 71,748 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (g) 124,647 shares of common stock held by the Reporting Person."}],"balance_after":816547,"source":{"system":"sec-edgar","filing":"0001209191-18-042406","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118042406/doc4.xml","form_type":"4"}},{"id":3915788,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-05-29T20:23:55.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":94444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a deferred stock award of 94,444 restricted stock units with performance based vesting conditions. These restricted stock units shall vest in three equal annual installments on May 24, 2019, May 24, 2020 and May 24, 2021, and are linked to the achievement of a relative total shareholder return of the Issuer's common stock from May 24, 2018 to the earlier of (i) May 24, 2019 or (ii) upon a change of control (measured relative to the NASDAQ Biotechnology index and based on the 20-day trading average price before each such date). The target number of these restricted stock units that may be earned is reported above; the maximum amount is 150% of the number reported."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes (a) a deferred stock award of 94,444 restricted stock units with performance based vesting conditions, which shall vest in three equal installments on May 24, 2019, May 24, 2020 and May 24, 2021, contingent upon achievement of a performance condition tied to relative total shareholder return; and (b) all awards and common stock held by the Reporting Person as described in footnote 2 above."}],"balance_after":830742,"source":{"system":"sec-edgar","filing":"0001209191-18-033824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118033824/doc4.xml","form_type":"4"}},{"id":3915787,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-05-29T20:23:55.000Z","date":"2018-05-24","kind":"grant","acquired":true,"shares":94444,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a deferred stock award of 94,444 restricted stock units which shall vest in four equal installments on January 1, 2019, 2020, 2021 and 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 94,444 restricted stock units which shall vest in four equal installments on January 1, 2019, 2020, 2021 and 2022; (b) a deferred stock award of 268,206 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (c) a deferred stock award of 145,833 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (d) a deferred stock award of 17,225 restricted stock units which shall vest in full on January 1, 2019; (e) a deferred stock award of 71,748 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (f) 138,842 shares of common stock held by the Reporting Person."}],"balance_after":736298,"source":{"system":"sec-edgar","filing":"0001209191-18-033824","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118033824/doc4.xml","form_type":"4"}},{"id":4001342,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-12T21:25:49.000Z","date":"2018-03-09","kind":"sale","acquired":false,"shares":7800,"price":4.6,"value":35880.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.60 to $4.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes (a) a deferred stock award of 268,206 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (b) a deferred stock award of 145,833 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (c) a deferred stock award of 17,225 restricted stock units which shall vest in full on January 1, 2019; (d) a deferred stock award of 71,748 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (e) 138,842 shares of common stock held by the Reporting Person."}],"balance_after":641854,"source":{"system":"sec-edgar","filing":"0001209191-18-018911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118018911/doc4.xml","form_type":"4"}},{"id":4001341,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-12T21:25:49.000Z","date":"2018-03-08","kind":"sale","acquired":false,"shares":79222,"price":4.52,"value":358083.44,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.50 to $4.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 268,206 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (b) a deferred stock award of 145,833 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (c) a deferred stock award of 17,225 restricted stock units which shall vest in full on January 1, 2019; (d) a deferred stock award of 71,748 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (e) 146,642 shares of common stock held by the Reporting Person."}],"balance_after":649654,"source":{"system":"sec-edgar","filing":"0001209191-18-018911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118018911/doc4.xml","form_type":"4"}},{"id":4108046,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-01-04T13:49:39.000Z","date":"2018-01-01","kind":"tax_withholding","acquired":false,"shares":60108,"price":3.3,"value":198356.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were disposed to satisfy the Reporting Person's tax withholding obligation in connection with deferred stock awards previously granted to the Reporting Person which vested in part on January 1, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 268,206 restricted stock units which shall vest in three equal installments on January 1, 2019, 2020 and 2021; (b) a deferred stock award of 145,833 restricted stock units which shall vest in two equal installments on January 1, 2019 and 2020; (c) a deferred stock award of 17,225 restricted stock units which shall vest in full on January 1, 2019; (d) a deferred stock award of 71,748 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (e) 225,864 shares of common stock held by the Reporting Person."}],"balance_after":728876,"source":{"system":"sec-edgar","filing":"0001209191-18-001628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118001628/doc4.xml","form_type":"4"}},{"id":4284010,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-06-13T21:03:37.000Z","date":"2017-06-12","kind":"sale","acquired":false,"shares":22000,"price":2.66,"value":58520.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $2.65 to $2.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes (a) a deferred stock award of 357,609 restricted stock units which shall vest in four equal installments on January 1, 2018, 2019, 2020 and 2021; (b) a deferred stock award of 218,750 restricted stock units which shall vest in three equal installments on January 1, 2018, 2019 and 2020; (c) a deferred stock award of 34,450 restricted stock units which shall vest in two equal installments on January 1, 2018 and 2019; (d) a deferred stock award of 71,748 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (e) 106,427 shares of common stock held by the Reporting Person."}],"balance_after":788984,"source":{"system":"sec-edgar","filing":"0001209191-17-039532","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117039532/doc4.xml","form_type":"4"}},{"id":4284009,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-06-13T21:03:37.000Z","date":"2017-06-12","kind":"purchase","acquired":true,"shares":22000,"price":2.76,"value":60720.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $2.70 to $2.80. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 357,609 restricted stock units which shall vest in four equal installments on January 1, 2018, 2019, 2020 and 2021; (b) a deferred stock award of 218,750 restricted stock units which shall vest in three equal installments on January 1, 2018, 2019 and 2020; (c) a deferred stock award of 34,450 restricted stock units which shall vest in two equal installments on January 1, 2018 and 2019; (d) a deferred stock award of 71,748 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (e) 128,427 shares of common stock held by the Reporting Person."}],"balance_after":810984,"source":{"system":"sec-edgar","filing":"0001209191-17-039532","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117039532/doc4.xml","form_type":"4"}},{"id":4301564,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-31T00:36:03.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":357609,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a deferred stock award of 357,609 restricted stock units which shall vest in four equal installments on January 1, 2018, 2019, 2020 and 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 357,609 restricted stock units which shall vest in four equal installments on January 1, 2018, 2019, 2020 and 2021; (b) a deferred stock award of 218,750 restricted stock units which shall vest in three equal installments on January 1, 2018, 2019 and 2020; (c) a deferred stock award of 34,450 restricted stock units which shall vest in two equal installments on January 1, 2018 and 2019; (d) a deferred stock award of 71,748 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (e) 106,427 shares of common stock held by the Reporting Person."}],"balance_after":788984,"source":{"system":"sec-edgar","filing":"0001209191-17-036298","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117036298/doc4.xml","form_type":"4"}},{"id":4503500,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-04T22:11:50.000Z","date":"2017-01-01","kind":"tax_withholding","acquired":false,"shares":31248,"price":3.05,"value":95306.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were disposed to satisfy the Reporting Person's tax withholding obligation in connection with deferred stock awards previously granted to the Reporting Person which vested in part on January 1, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 218,750 restricted stock units which shall vest in three equal installments on January 1, 2018, 2019 and 2020; (b) a deferred stock award of 34,450 restricted stock units which shall vest in two equal installments on January 1, 2018 and 2019; (c) a deferred stock award of 71,748 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (c) 106,427 shares of common stock held by the Reporting Person."}],"balance_after":431375,"source":{"system":"sec-edgar","filing":"0001209191-17-001160","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117001160/doc4.xml","form_type":"4"}},{"id":4568251,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":156101,"kind":"person","name":"Duchemin Jeffrey","position":1,"cik":"0001585223","reported_name":"Duchemin Jeffrey","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-11-03T20:12:22.000Z","date":"2016-11-03","kind":"purchase","acquired":true,"shares":15000,"price":2.42,"value":36300.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in several trades between $2.35 and $2.50. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 291,667 restricted stock units which shall vest in four equal installments on January 1, 2017, 2018, 2019 and 2020; (b) a deferred stock award of 51,675 restricted stock units which shall vest in three equal installments on January 1, 2017, 2018 and 2019; (c) a deferred stock award of 71,748 restricted stock units with performance based vesting conditions, which shall vest on August 3, 2018 contingent upon achievement of a performance condition tied to relative total shareholder return; and (c) 47,533 shares of common stock held by the Reporting Person."}],"balance_after":462623,"source":{"system":"sec-edgar","filing":"0001209191-16-148159","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919116148159/doc4.xml","form_type":"4"}}]}